- Markets
- Healthcare
- LOTUSEYE
LOTUSEYE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Lotus Eye Hospital do?
Lotus Eye Care Hospital Ltd is a hi-tech super specialty eye care hospital offering Specialty Treatments, Institute of Optometry, Community Ophthalmology, Medical Tourism, and Eye Bank services.
Who are the competitors of Lotus Eye Hospital?
Lotus Eye Hospital major competitors are Vaidya Sane Ayur Lab, Fortis MalarHospital, Sangani Hospitals, Asarfi Hospital Ltd., Choksi Lab, Constronics Infra, Aspira Pathlab&Diagn. Market Cap of Lotus Eye Hospital is ₹139 Crs. While the median market cap of its peers are ₹103 Crs.
Is Lotus Eye Hospital financially stable compared to its competitors?
Lotus Eye Hospital seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Lotus Eye Hospital pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Lotus Eye Hospital latest dividend payout ratio is 35.68% and 3yr average dividend payout ratio is 32.01%
How has Lotus Eye Hospital allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is Lotus Eye Hospital balance sheet?
Balance sheet of Lotus Eye Hospital is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Lotus Eye Hospital improving?
No, profit is decreasing. The profit of Lotus Eye Hospital is ₹0.51 Crs for TTM, ₹2.91 Crs for Mar 2024 and ₹4.08 Crs for Mar 2023.
Is the debt of Lotus Eye Hospital increasing or decreasing?
Yes, The debt of Lotus Eye Hospital is increasing. Latest debt of Lotus Eye Hospital is -₹4.54 Crs as of Sep-24. This is greater than Mar-24 when it was -₹13.78 Crs.
Is Lotus Eye Hospital stock expensive?
Yes, Lotus Eye Hospital is expensive. Latest PE of Lotus Eye Hospital is 270, while 3 year average PE is 48.93. Also latest EV/EBITDA of Lotus Eye Hospital is 30.85 while 3yr average is 25.17.
Has the share price of Lotus Eye Hospital grown faster than its competition?
Lotus Eye Hospital has given lower returns compared to its competitors. Lotus Eye Hospital has grown at ~11.34% over the last 1yrs while peers have grown at a median rate of 46.21%
Is the promoter bullish about Lotus Eye Hospital?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 40.22% and last quarter promoter holding is 40.14%.
Are mutual funds buying/selling Lotus Eye Hospital?
There is Insufficient data to gauge this.